Page of

Medication treatment for anxiety, depression, schizophrenia, and bipolar disorder in the community setting 

Medication treatment for anxiety, depression, schizophrenia, and bipolar disorder in the community setting
Chapter:
Medication treatment for anxiety, depression, schizophrenia, and bipolar disorder in the community setting
Source:
Oxford Textbook of Community Mental Health
Author(s):

Jonathan Shaywitz

and Stephen Marder

DOI:
10.1093/med/9780199565498.003.0109

In the community setting, four of the most common mental health syndromes affecting individuals include anxiety, depression, psychosis, and bipolar disorder. While the disorders can be quite debilitating, fortunately recent advances in both behavioural therapy as well as pharmacotherapy have helped improve the lives of countless individuals. In this chapter we will focus our discussion on pharmacotherapy with an emphasis on providing practical information that will be particularly useful to the community psychiatrist in selecting the most optimal therapeutic agents for his/her patient. Specifically, we first briefly introduce each clinical syndrome, and the classes of medications used in treatment; then we go on to discuss in detail each disorder within the general syndrome with the current pharmacological treatments variable for each entity, including both their short term and long term efficacy and then discuss the current pharmacological treatments available for each entity, including both their short-term and long-term efficacy. The potential adverse (side) effects associated with each of these medications will also be discussed. Our goal is for this chapter to serve as a clinical tool box providing the reader with a practical and effective approach to these very common psychiatric disorders.

Sign In

Copyright © 2021. All rights reserved.